Genpact (NYSE:G - Free Report) had its price target upped by Mizuho from $45.00 to $55.00 in a report published on Monday,Benzinga reports. The firm currently has a neutral rating on the business services provider's stock.
Several other analysts have also recently weighed in on the stock. Jefferies Financial Group raised shares of Genpact from a "hold" rating to a "buy" rating and raised their target price for the company from $44.00 to $55.00 in a report on Tuesday, January 21st. Needham & Company LLC lifted their price objective on shares of Genpact from $55.00 to $65.00 and gave the stock a "buy" rating in a research report on Friday. Robert W. Baird boosted their target price on shares of Genpact from $44.00 to $48.00 and gave the stock a "neutral" rating in a research note on Friday, November 8th. Finally, TD Cowen upgraded Genpact from a "hold" rating to a "buy" rating and raised their price target for the company from $45.00 to $60.00 in a research note on Friday. Six equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of "Hold" and an average target price of $48.44.
Check Out Our Latest Analysis on Genpact
Genpact Trading Up 0.6 %
G traded up $0.34 during mid-day trading on Monday, hitting $54.78. 2,119,869 shares of the stock were exchanged, compared to its average volume of 1,527,999. The company has a market cap of $9.66 billion, a PE ratio of 19.29, a PEG ratio of 1.63 and a beta of 1.20. The company has a current ratio of 1.85, a quick ratio of 1.85 and a debt-to-equity ratio of 0.50. The firm's fifty day moving average is $45.25 and its two-hundred day moving average is $41.55. Genpact has a 1-year low of $30.23 and a 1-year high of $56.76.
Genpact (NYSE:G - Get Free Report) last posted its quarterly earnings data on Thursday, February 6th. The business services provider reported $0.82 EPS for the quarter, missing the consensus estimate of $0.86 by ($0.04). Genpact had a net margin of 10.77% and a return on equity of 22.61%. Equities analysts forecast that Genpact will post 3.08 earnings per share for the current fiscal year.
Genpact Increases Dividend
The company also recently announced a quarterly dividend, which will be paid on Wednesday, March 26th. Stockholders of record on Tuesday, March 11th will be given a dividend of $0.17 per share. The ex-dividend date of this dividend is Tuesday, March 11th. This represents a $0.68 dividend on an annualized basis and a dividend yield of 1.24%. This is a boost from Genpact's previous quarterly dividend of $0.15. Genpact's payout ratio is 21.48%.
Insider Activity
In related news, CEO Balkrishan Kalra sold 9,000 shares of the firm's stock in a transaction dated Monday, November 25th. The stock was sold at an average price of $46.40, for a total transaction of $417,600.00. Following the transaction, the chief executive officer now owns 267,404 shares of the company's stock, valued at $12,407,545.60. This trade represents a 3.26 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, SVP Piyush Mehta sold 12,000 shares of the business's stock in a transaction dated Friday, January 10th. The shares were sold at an average price of $42.83, for a total value of $513,960.00. Following the completion of the transaction, the senior vice president now owns 151,182 shares in the company, valued at $6,475,125.06. This trade represents a 7.35 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders sold 35,058 shares of company stock valued at $1,558,675. Insiders own 2.80% of the company's stock.
Institutional Trading of Genpact
A number of hedge funds have recently added to or reduced their stakes in the stock. SRH Advisors LLC acquired a new position in shares of Genpact during the fourth quarter worth about $26,000. Manchester Capital Management LLC acquired a new position in Genpact during the 4th quarter worth approximately $38,000. Smartleaf Asset Management LLC increased its position in Genpact by 416.5% during the 4th quarter. Smartleaf Asset Management LLC now owns 971 shares of the business services provider's stock worth $41,000 after purchasing an additional 783 shares during the period. UMB Bank n.a. raised its stake in shares of Genpact by 55.7% during the 4th quarter. UMB Bank n.a. now owns 1,210 shares of the business services provider's stock worth $52,000 after buying an additional 433 shares in the last quarter. Finally, J.Safra Asset Management Corp lifted its holdings in shares of Genpact by 38.8% in the 4th quarter. J.Safra Asset Management Corp now owns 1,622 shares of the business services provider's stock valued at $69,000 after buying an additional 453 shares during the period. 96.03% of the stock is owned by institutional investors and hedge funds.
About Genpact
(
Get Free Report)
Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.
Recommended Stories
![Analyst Recommendations for Genpact (NYSE:G)](https://www.marketbeat.com/scripts/RatingsChart.ashx?Prefix=NYSE&Symbol=G)
Before you consider Genpact, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genpact wasn't on the list.
While Genpact currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.